The genomic landscape of breast cancer as a therapeutic roadmap

Cancer Discov. 2013 Jan;3(1):27-34. doi: 10.1158/2159-8290.CD-12-0462.

Abstract

The application of high-throughput techniques to profile DNA, RNA, and protein in breast cancer samples from hundreds of patients has profoundly increased our knowledge of the disease. The etiologic events that drive breast cancer are finally coming into focus and should be used to set priorities for clinical trials. In this Prospective, we summarize some of the headline conclusions from 6 recent breast cancer "omics profiling" articles in Nature, with an emphasis on the implications for systemic therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • Female
  • Genomics
  • Humans
  • Mutation
  • Ovarian Neoplasms / genetics
  • Protein Kinases / genetics
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estrogen / metabolism

Substances

  • Receptors, Estrogen
  • Protein Kinases
  • ERBB2 protein, human
  • Receptor, ErbB-2